Gagnon Suzanne 4
4 · Sun BioPharma, Inc. · Filed Sep 24, 2019
Insider Transaction Report
Form 4
Gagnon Suzanne
DirectorChief Medical Officer
Transactions
- Purchase
Common Stock
2019-09-20+7,142→ 8,142 total(indirect: By Trust) - Purchase
Warrants (right to buy)
2019-09-20+7,142→ 7,142 total(indirect: By Trust)Exercise: $4.00From: 2019-09-20Exp: 2024-09-20→ Common Stock (7,142 underlying)
Holdings
- 43,000
Common Stock
Footnotes (1)
- [F1]Reported securities purchased as one share of common stock and one warrant to purchase one share of common stock for a combined price of $3.50 per "unit."